the US-Algeria Business Council, the Embassy of Algeria in Washington, DC, and the Ministry of Health of Algeria will convene the ALGERIA 2020 Leadership Committee Meeting with executives from the international pharmaceutical sector.
On January 19-20, 2015 - Algiers, Algeria
On January 19-20, 2015, the US-Algeria Business Council, the Embassy of Algeria in Washington, DC, and the Ministry of Health of Algeria will convene the ALGERIA 2020 Leadership Committee Meeting in Algiers, Algeria, with executives from the international pharmaceutical sector.
This meeting will be a follow-up strategy session to the signing of the ALGERIA 2020 Memorandum of Understanding between the National Drug Testing Laboratory and PhRMA at the 2014 BIO International Convention in San Diego.
The ALGERIA 2020 Leadership Committee will designate three working groups with specific avenues of activity to implement significant upgrades in the healthcare system in Algeria. The three avenues are: Educational & Training Exchanges, Regulatory Harmonization and Drug Development & Manufacturing.